LungLife AI, Inc.
LLAI.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | £14,924 | £26,176 | £40,375 | £71,333 |
| - Cash | £2,724 | £3,088 | £14,628 | £20,874 |
| + Debt | £346 | £601 | £809 | £10,630 |
| Enterprise Value | £12,546 | £23,689 | £26,555 | £61,089 |
| Revenue | £46 | £24 | £196 | £205 |
| % Growth | 91.7% | -87.7% | -4.7% | – |
| Gross Profit | £46 | £24 | £99 | £17 |
| % Margin | 100% | 100% | 50.8% | 8.3% |
| EBITDA | -£5,111 | -£7,265 | -£6,688 | -£3,779 |
| % Margin | -11,110.9% | -30,270.8% | -3,419.8% | -1,841.9% |
| Net Income | -£5,413 | -£7,606 | -£7,444 | -£5,616 |
| % Margin | -11,767.4% | -31,691.7% | -3,806.5% | -2,737.2% |
| EPS Diluted | -0.21 | -0.3 | -0.47 | -0.22 |
| % Growth | 30% | 36.2% | -113.6% | – |
| Operating Cash Flow | -£5,020 | -£5,845 | -£7,539 | -£2,874 |
| Capital Expenditures | -£77 | -£85 | -£1,847 | -£5 |
| Free Cash Flow | -£5,097 | -£5,930 | -£9,386 | -£2,879 |